Acute kidney injury (AKI) is a significant factor predisposing chronic kidney disease (CKD), however the factors mediating CKD progression are not clear. Work from the previous project period identified T-helper 17 cells (Th-17) as a primary lymphocyte population activated by AKI and further demonstrated that it is strongly activated by exposure of post AKI rats to high salt diet. Recent preliminary data indicate a potential role for altered lymphocyte intracellular calcium signaling in mediating enhanced IL17 activity. The overarching hypothesis to be tested is that AKI results in persistent IL-17 activity from CD4+ cells and this activity is integral to the subsequent development of CKD. As such, Specific aim 1 of this application will investigate the role of Th-17 cells in the mediation of the AKI to CKD transition in rats. The studies will utilize a rat model of AKI-to CKD established in our laboratory. Two approaches will be used to inhibit Th17 activity. In one series of studies, we will use an antibody-based approach to block IL17 activity in rats in vivo. Additional studies will utilize a transgenic rat in which the ROR?T gene has been mutated. This rat shows impaired activation of Th-17 cells following AKI and lymphocytes obtained from these rats show an impaired IL17 responses in vitro. Using either approach we will test whether Th17 cells activated by elevated dietary salt following recovery from AKI participate in the processes of renal fibrosis, sodium sensitive hypertension, altered vascular reactivity and distant organ injury following AKI Specific aim 2 of this application will more precisely examine altered lymphocyte signaling associated with IL17. Isolated lymphocytes from normal or post AKI rats will be stimulated in vitro (by elevated Na+ and Ang II) for enhanced IL17 synthesis. The goal of these studies will be to determine how prolonged enhanced IL17 responses to are retained in CD4 cells following resolution of renal injury. We will also investigate potential physiologically relevant mediators that may activate these responses in vivo. Additional studies in this aim will investigate contribution of the store-operated Ca++ Oria1 to altered Ca signaling and the IL17 response. Finally studies in this aim will seek to investigate the effect of in vivo inhibition of Oria-1 on the activation of Th-17 cells and the AKI to CKD transition.
Specific aim 3 will determine whether activation of Th17 cells may underlie the AKI to CKD transition in human patients. These studies will utilize samples available from the ASSESS-AKI consortium which has collected samples from AKI patients for up to 4 years following hospital discharge. We will compare circulating Th17 cytokines as an initial step to determine the activity of this pathway in patients with AKI who progress versus patients who recovery renal function as well as control patients.

Public Health Relevance

Acute kidney injury (AKI) is the most common renal disease requiring hospitalization is becoming a widely recognized contributor toward the development of chronic kidney disease (CKD). The current program will investigate the role of specific T-helper 17 cells, and the primary cytokine IL17, in the transition of AKI to CKD in rats and investigate the biochemical signaling pathways mediating IL17 production in lymphocytes. The study will also determine if Th17 cytokines are elevated in population of patients who have been diagnosed with AKI and have progressed to CKD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK063114-17
Application #
9976522
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Schulman, Ivonne Hernandez
Project Start
2003-07-01
Project End
2022-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
17
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Physiology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Kolb, Alexander L; Corridon, Peter R; Zhang, Shijun et al. (2018) Exogenous Gene Transmission of Isocitrate Dehydrogenase 2 Mimics Ischemic Preconditioning Protection. J Am Soc Nephrol 29:1154-1164
Mehrotra, Purvi; Collett, Jason A; Gunst, Susan J et al. (2018) Th17 cells contribute to pulmonary fibrosis and inflammation during chronic kidney disease progression after acute ischemia. Am J Physiol Regul Integr Comp Physiol 314:R265-R273
Basile, D P; Collett, J A; Yoder, M C (2018) Endothelial colony-forming cells and pro-angiogenic cells: clarifying definitions and their potential role in mitigating acute kidney injury. Acta Physiol (Oxf) 222:
Collett, Jason A; Mehrotra, Purvi; Crone, Allison et al. (2017) Endothelial colony-forming cells ameliorate endothelial dysfunction via secreted factors following ischemia-reperfusion injury. Am J Physiol Renal Physiol 312:F897-F907
Collett, Jason A; Traktuev, Dmitry O; Mehrotra, Purvi et al. (2017) Human adipose stromal cell therapy improves survival and reduces renal inflammation and capillary rarefaction in acute kidney injury. J Cell Mol Med 21:1420-1430
Mehrotra, Purvi; Collett, Jason A; McKinney, Seth D et al. (2017) IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats. Am J Physiol Renal Physiol 312:F385-F397
Collett, Jason A; Corridon, Peter R; Mehrotra, Purvi et al. (2017) Hydrodynamic Isotonic Fluid Delivery Ameliorates Moderate-to-Severe Ischemia-Reperfusion Injury in Rat Kidneys. J Am Soc Nephrol 28:2081-2092
Basile, David P; Mehrotra, Purvi (2017) Surprising Enhancement of Fibrosis by Tubule-Specific Deletion of the TGF-? Receptor: A New Twist on an Old Paradigm. J Am Soc Nephrol 28:3427-3429
de Bragan├ža, Ana C; Volpini, Rildo A; Mehrotra, Purvi et al. (2016) Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury. Physiol Rep 4:
Basile, David P; Bonventre, Joseph V; Mehta, Ravindra et al. (2016) Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments. J Am Soc Nephrol 27:687-97

Showing the most recent 10 out of 38 publications